I queried the skin-analysis statistics accumulated since the clinic opened with a script and split them by age group and sex. Most patients' scores were packed into a narrow range.
Absolute scores could not explain the differences between patients, so I switched to showing each patient's relative position within their cohort.
I proposed a Q1/Q3 quartile-based formula to the leadership. After applying it, I re-ran the statistics, confirmed that the score concentration had eased, and adopted it as the final calculation.
Mean-based normalisation still left most patients in a narrow band with no visible difference. I interpolated linearly between p10 and p90 markers to place each patient within the cohort, and used 25/50/75 quartile cut-offs to classify severity into four levels. Age groups with too few samples fell back to the parent cohort, and unknown sex fell back to the combined cohort.
The normalisation is a temporary correction for in-product display; I judged the root cause to be model performance. I shared the analysis and it became a company-level model problem definition.
The DERMA:CODE model is currently being retrained, and I am taking part in building the annotation tool (human-in-the-loop) that produces the training data.